Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Clinical Roundup

Cedars-Sinai to develop AI tool that predicts pancreatic cancer risk in Black patients

December 06, 2024
Vol.50 No.45
Drugs & Targets

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

December 06, 2024
Vol.50 No.45
In Brief

Argonne National Laboratory receives $22M from ARPA-H to accelerate cancer therapy, vaccine discoveries using AI

November 22, 2024
Vol.50 No.44
Clinical Roundup

Model created by Cedars-Sinai investigators could speed patient selection for clinical trials

November 22, 2024
Vol.50 No.44
Ready or not, AI-based decision support tools are entering oncology clinics
Regulatory News

Ready or not, AI-based decision support tools are entering oncology clinics
Regulators and health systems must adapt

November 15, 2024
Vol.50 No.43
By McKenzie Prillaman
In Brief

J. Leonard Lichtenfeld joins SpotitEarly as CMO

November 15, 2024
Vol.50 No.43
Clinical Roundup

AI may be more accurate vs. traditional methods at classifying patients into prostate cancer risk groups

November 08, 2024
Vol.50 No.42
Clinical Roundup

Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment

November 08, 2024
Vol.50 No.42
In Brief

OmniaBio opens commercial manufacturing facility in Canada, bringing cell and gene therapies to patients

October 25, 2024
Vol.50 No.40
Clinical Roundup

East Alabama Medical Center, Inflo Health, ACR ImPower program collaboration boosts recommendations follow-up by 74%

October 25, 2024
Vol.50 No.40

Posts navigation

Previous1…8910…16Next

Trending Stories

  • “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
    In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process
  • DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
    Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account